Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
7 questions on Biogen's revival of a failed Alzheimer's drug
Biopharma Dive
Tue, 10/22/19 - 11:07 pm
Biogen
aducanumab
Alzheimer's disease
Alzheimer’s patients in Biogen trial, jolted by revival of drug, press for access once again
Stat
Tue, 10/22/19 - 10:56 pm
Biogen
Alzheimer's disease
FDA
aducanumab
Biogen resurrects aducanumab, arguing expanded data set supports FDA filing in Alzheimer's
Fierce Biotech
Tue, 10/22/19 - 11:05 am
Biogen
Alzheimer's disease
aducanumab
FDA
Biogen (BIIB) Q3 Earnings & Sales Beat Estimates
NASDAQ
Tue, 10/22/19 - 11:04 am
Biogen
earnings
A new company enters the Tecfidera fight, offering to kill two birds
Endpoints
Tue, 10/22/19 - 10:29 am
Biogen
Tecfidera
MS
flushing
Vitalis Pharmaceuticals
Upcoming events – Sage targets depression and Biogen aims for lupus
EP Vantage
Fri, 10/4/19 - 10:03 am
SAGE Therapeutics
SAGE-217
major depressive disorder
Biogen
BIIB059
lupus
Biogen loses head of R&D, the latest blow to the struggling drugmaker
Bizjournals
Tue, 10/1/19 - 09:58 am
Biogen
R&D
Michael Ehlers
LImelight Bio
Biotechs Fly Sideways In Quiet Week — 5 News Items You May Have Missed
Investors Business Daily
Sat, 09/21/19 - 12:28 pm
Wave Life Sciences
suvodirsen
DMD
Merck
Keytruda
Biogen
Spinraza
Zoetis
Europe
animal health
Jazz Pharmaceuticals
JZP-258
narcolepsy
Biogen ramps up its SMA rivalry with Novartis with new Spinraza trial
Fierce Pharma
Wed, 09/18/19 - 11:21 am
Biogen
clinical trials
Spinraza
SMA
spinal muscular atrophy
Novartis
Biogen stops Phase 2 study in another hit to 'high-risk' pipeline
Biopharma Dive
Tue, 09/17/19 - 03:38 pm
Biogen
clinical trials
IPF
idiopathic pulmonary fibrosis
BG00011
Biogen taps machine learning to help answer doctors' drug questions
Fierce Pharma
Mon, 09/16/19 - 10:18 pm
Biogen
Lexalytics
machine learning
artificial intelligence
physicians
Biogen, Eisai throw out remaining Alzheimer's BACE hope
Fierce Biotech
Fri, 09/13/19 - 10:45 am
Biogen
Eisai
Alzheimer's disease
BACE inhibitors
elenbecestat
aducanumab
Investors lost big as Alzheimer’s R&D went over the cliff in 2019. Will they ever come back?
Endpoints
Wed, 09/11/19 - 11:39 pm
Alzheimer's disease
R&D
Biogen
Neurotrope
Biogen, wrestling MS rivals, touts 10 year-plus Tecfidera data
Fierce Pharma
Wed, 09/11/19 - 10:26 am
Biogen
Tecfidera
MS
multiple sclerosis
Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in
Fierce Pharma
Thu, 08/29/19 - 08:18 pm
multiple sclerosis
MS
drug pricing
Biogen
Roche
Sanofi
Novartis
Teva Pharmaceutical
Bayer
Upcoming events – United seeks a Distinct hit, and Biogen nears a rare catalyst
EP Vantage
Fri, 08/9/19 - 10:26 am
United Therapeutics
Unituxin
SCLC
Biogen
MAb BIIB092
The patent play: Biogen gets a PhIII boost for its bit-better take on the blockbuster MS franchise drug Tecfidera
Endpoints
Tue, 07/30/19 - 11:29 am
Biogen
Alkermes
MS
multiple sclerosis
Vumerity
clinical trials
AbbVie scraps an anti-tau study, and that may foretell more big trouble for a beleaguered Biogen
Endpoints
Fri, 07/26/19 - 11:00 am
AbbVie
Biogen
anti-tau antibodies
ABBV-8E12
progressive supranuclear palsy
Biogen turns to eye, immune diseases to balance neuro gamble
Biopharma Dive
Wed, 07/24/19 - 12:26 pm
Biogen
immune system
eye health
Neuroscience
Biogen beats estimates on multiple sclerosis therapy sales Reuters
Yahoo/Reuters
Tue, 07/23/19 - 10:07 am
Biogen
earnings
Tecfidera
Pages
« first
‹ previous
…
25
26
27
28
29
30
31
32
33
…
next ›
last »